Cargando…

Resolvin D1 mitigates energy metabolism disorder after ischemia–reperfusion of the rat lung

BACKGROUND: Energy metabolism disorder is a critical process in lung ischemia–reperfusion injury (LIRI). This study was aimed to determine the effects of resolvin D1 (RvD1) on the energy metabolism in LIRI. METHODS: Forty Sprague–Dawley rats were divided into the following groups: Sham group; untrea...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Qifeng, Wu, Ji, Hua, Qingwang, Lin, Zhiyong, Ye, Leping, Zhang, Weixi, Wu, Guowei, Du, Jie, Xia, Jie, Chu, Maoping, Hu, Xingti
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4806414/
https://www.ncbi.nlm.nih.gov/pubmed/27009328
http://dx.doi.org/10.1186/s12967-016-0835-7
_version_ 1782423232060588032
author Zhao, Qifeng
Wu, Ji
Hua, Qingwang
Lin, Zhiyong
Ye, Leping
Zhang, Weixi
Wu, Guowei
Du, Jie
Xia, Jie
Chu, Maoping
Hu, Xingti
author_facet Zhao, Qifeng
Wu, Ji
Hua, Qingwang
Lin, Zhiyong
Ye, Leping
Zhang, Weixi
Wu, Guowei
Du, Jie
Xia, Jie
Chu, Maoping
Hu, Xingti
author_sort Zhao, Qifeng
collection PubMed
description BACKGROUND: Energy metabolism disorder is a critical process in lung ischemia–reperfusion injury (LIRI). This study was aimed to determine the effects of resolvin D1 (RvD1) on the energy metabolism in LIRI. METHODS: Forty Sprague–Dawley rats were divided into the following groups: Sham group; untreated ischemia–reperfusion (IR) control; IR treated with normal saline (IR-NS); and IR treated with RvD1 (IR-RV) (100 μg/kg, iv). LIRI and energy metabolism disorder were determined in these rats. RESULTS: The results revealed that the levels of interleukin (IL)-1β, tumor necrosis factor-α, IL-10, monocyte chemoattractant protein-1, macrophage inflammatory protein-2, cytokine-induced neutrophil chemoattractant-1, injured alveoli rate, apoptosis index, pulmonary permeability index, malondialdehyde, ADP, and lactic acid were increased, whereas the levels of ATP, ATP/ADP, glycogen, Na(+)–K(+)-ATPase, superoxide dismutase, glutathione peroxidase activity, pulmonary surfactant associated protein-A, and oxygenation index were decreased in rats with LIRI. Except for IL-10, all these biomarkers of LIRI and its related energy metabolism disorder were significantly inhibited by RvD1 treatment. In addition, histological analysis via hematoxylin–eosin staining, and transmission electron microscopy confirmed that IR-induced structure damages of lung tissues were reduced by RvD1. CONCLUSION: RvD1 improves the energy metabolism of LIRI disturbance, protects the mitochondrial structure and function, increases the ATP, glycogen content and Na(+)–K(+)-ATPase activity of lung tissue, balances the ratio of ATP/ADP and finally decreases the rate of apoptosis, resulting in the protection of IR-induced lung injury. The improved energy metabolism after LIRI may be related to the reduced inflammatory response, the balance of the oxidative/antioxidant and the pro-inflammatory/anti-inflammatory systems in rats. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12967-016-0835-7) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-4806414
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-48064142016-03-24 Resolvin D1 mitigates energy metabolism disorder after ischemia–reperfusion of the rat lung Zhao, Qifeng Wu, Ji Hua, Qingwang Lin, Zhiyong Ye, Leping Zhang, Weixi Wu, Guowei Du, Jie Xia, Jie Chu, Maoping Hu, Xingti J Transl Med Research BACKGROUND: Energy metabolism disorder is a critical process in lung ischemia–reperfusion injury (LIRI). This study was aimed to determine the effects of resolvin D1 (RvD1) on the energy metabolism in LIRI. METHODS: Forty Sprague–Dawley rats were divided into the following groups: Sham group; untreated ischemia–reperfusion (IR) control; IR treated with normal saline (IR-NS); and IR treated with RvD1 (IR-RV) (100 μg/kg, iv). LIRI and energy metabolism disorder were determined in these rats. RESULTS: The results revealed that the levels of interleukin (IL)-1β, tumor necrosis factor-α, IL-10, monocyte chemoattractant protein-1, macrophage inflammatory protein-2, cytokine-induced neutrophil chemoattractant-1, injured alveoli rate, apoptosis index, pulmonary permeability index, malondialdehyde, ADP, and lactic acid were increased, whereas the levels of ATP, ATP/ADP, glycogen, Na(+)–K(+)-ATPase, superoxide dismutase, glutathione peroxidase activity, pulmonary surfactant associated protein-A, and oxygenation index were decreased in rats with LIRI. Except for IL-10, all these biomarkers of LIRI and its related energy metabolism disorder were significantly inhibited by RvD1 treatment. In addition, histological analysis via hematoxylin–eosin staining, and transmission electron microscopy confirmed that IR-induced structure damages of lung tissues were reduced by RvD1. CONCLUSION: RvD1 improves the energy metabolism of LIRI disturbance, protects the mitochondrial structure and function, increases the ATP, glycogen content and Na(+)–K(+)-ATPase activity of lung tissue, balances the ratio of ATP/ADP and finally decreases the rate of apoptosis, resulting in the protection of IR-induced lung injury. The improved energy metabolism after LIRI may be related to the reduced inflammatory response, the balance of the oxidative/antioxidant and the pro-inflammatory/anti-inflammatory systems in rats. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12967-016-0835-7) contains supplementary material, which is available to authorized users. BioMed Central 2016-03-24 /pmc/articles/PMC4806414/ /pubmed/27009328 http://dx.doi.org/10.1186/s12967-016-0835-7 Text en © Zhao et al. 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Zhao, Qifeng
Wu, Ji
Hua, Qingwang
Lin, Zhiyong
Ye, Leping
Zhang, Weixi
Wu, Guowei
Du, Jie
Xia, Jie
Chu, Maoping
Hu, Xingti
Resolvin D1 mitigates energy metabolism disorder after ischemia–reperfusion of the rat lung
title Resolvin D1 mitigates energy metabolism disorder after ischemia–reperfusion of the rat lung
title_full Resolvin D1 mitigates energy metabolism disorder after ischemia–reperfusion of the rat lung
title_fullStr Resolvin D1 mitigates energy metabolism disorder after ischemia–reperfusion of the rat lung
title_full_unstemmed Resolvin D1 mitigates energy metabolism disorder after ischemia–reperfusion of the rat lung
title_short Resolvin D1 mitigates energy metabolism disorder after ischemia–reperfusion of the rat lung
title_sort resolvin d1 mitigates energy metabolism disorder after ischemia–reperfusion of the rat lung
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4806414/
https://www.ncbi.nlm.nih.gov/pubmed/27009328
http://dx.doi.org/10.1186/s12967-016-0835-7
work_keys_str_mv AT zhaoqifeng resolvind1mitigatesenergymetabolismdisorderafterischemiareperfusionoftheratlung
AT wuji resolvind1mitigatesenergymetabolismdisorderafterischemiareperfusionoftheratlung
AT huaqingwang resolvind1mitigatesenergymetabolismdisorderafterischemiareperfusionoftheratlung
AT linzhiyong resolvind1mitigatesenergymetabolismdisorderafterischemiareperfusionoftheratlung
AT yeleping resolvind1mitigatesenergymetabolismdisorderafterischemiareperfusionoftheratlung
AT zhangweixi resolvind1mitigatesenergymetabolismdisorderafterischemiareperfusionoftheratlung
AT wuguowei resolvind1mitigatesenergymetabolismdisorderafterischemiareperfusionoftheratlung
AT dujie resolvind1mitigatesenergymetabolismdisorderafterischemiareperfusionoftheratlung
AT xiajie resolvind1mitigatesenergymetabolismdisorderafterischemiareperfusionoftheratlung
AT chumaoping resolvind1mitigatesenergymetabolismdisorderafterischemiareperfusionoftheratlung
AT huxingti resolvind1mitigatesenergymetabolismdisorderafterischemiareperfusionoftheratlung